Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, March 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 355 articles:
HTML format


 

Single Articles

  1. HUANG X, Liu X, Du B, Liu X, et al
    LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  2. JORGENSEN SF, Andersen B, Rebolj M, Njor SH, et al
    Gaps between recommendations and their implementation: A register-based study of follow-up after abnormalities in cervical cancer screening.
    Prev Med. 2021 Feb 23:106468. doi: 10.1016/j.ypmed.2021.106468.
    PubMed    
    Abstract available

  3. KIM SI, Kim TH, Lee M, Kim HS, et al
    Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Yonsei Med J. 2021;62:231-239.
    PubMed    
    Abstract available

  4. KONG X, Wang JS, Yang H
    Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
    J Biochem Mol Toxicol. 2021 Feb 25:e22749. doi: 10.1002/jbt.22749.
    PubMed    
    Abstract available

  5. LOURENCO DE FREITAS N, Deberaldini MG, Gomes D, Pavan AR, et al
    Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.
    Front Cell Dev Biol. 2021;8:592868.
    PubMed    
    Abstract available

  6. SUN Y, Zhang R, Zhou S, Ji Y, et al
    Erratum: Overexpression of Notch1 is associated with the progression of cervical cancer.
    Oncol Lett. 2021;21:134.
    PubMed    
    Abstract available

  7. SHI H, Zhong F, Yi X, Shi Z, et al
    Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer.
    Front Genet. 2021;11:616998.
    PubMed    
    Abstract available

  8. GHANAAT M, Goradel NH, Arashkia A, Ebrahimi N, et al
    Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer.
    Acta Pharmacol Sin. 2021 Feb 25. pii: 10.1038/s41401-021-00616.
    PubMed    
    Abstract available

  9. FARAHAT FM, Faqih NT, Alharbi RS, Mudarris RI, et al
    Epidemiological characteristics of cervical cancer in a tertiary care hospital, western Saudi Arabia: A retrospective record-based analysis from 2002-2018.
    Saudi Med J. 2021;42:338-341.
    PubMed    
    Abstract available

  10. MOSCICKI AB, Chang C, Vangala S, Zhou X, et al
    Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence.
    Am J Prev Med. 2021 Feb 22. pii: S0749-3797(21)00057.
    PubMed    
    Abstract available

  11. ZHANG Y, Qiu S, Guo Y, Zhang J, et al
    Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
    Technol Cancer Res Treat. 2021;20:1533033821995281.
    PubMed    
    Abstract available

  12. ZHANG Y, Lu H, Zhang J, Wang S, et al
    Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
    Future Oncol. 2021 Feb 26. doi: 10.2217/fon-2020-1024.
    PubMed    
    Abstract available

  13. KUROKI L, Massad LS, Martin A, Liu J, et al
    Addressing Unmet Basic Needs to Improve Colposcopy Adherence Among Women With Abnormal Cervical Cancer Screening.
    J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99356.
    PubMed    
    Abstract available

  14. JODRY D, Blemur D, Nguyen ML, Kuhn T, et al
    Criminal Justice Involvement and Abnormal Cervical Cancer Screening Results Among Women in an Urban Safety Net Hospital.
    J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99354.
    PubMed    
    Abstract available

  15. LONG ME, Chantigian PDM, Weaver AL
    Would Women With Solid Organ Transplant Qualify for Triennial Cervical Cancer Screening as Recommended by the American College of Obstetricians and Gynecologists in 2016 and American Society for Colposcopy and Cervical Pathology in 2019?
    J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99353.
    PubMed    
    Abstract available

  16. FAN Q, Huang T, Sun X, Wang YW, et al
    HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
    Mol Carcinog. 2021 Feb 25. doi: 10.1002/mc.23292.
    PubMed    
    Abstract available

  17. EBELL MH
    HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer.
    Am Fam Physician. 2021;103:312.
    PubMed    


  18. JACOB RA, Abraham PS, Thomas FR, Navya V, et al
    Impact of indirect education on knowledge and perception on cervical cancer and its prevention among the parents of adolescent girls: an interventional school-based study.
    Ther Adv Vaccines Immunother. 2021;9:2515135521990268.
    PubMed    
    Abstract available

  19. DEGUARA M, Calleja N, England K
    Cervical cancer and screening: knowledge, awareness and attitudes of women in Malta.
    J Prev Med Hyg. 2021;61:E584-E592.
    PubMed    
    Abstract available

  20. YANG B, Chen J, Teng Y
    CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration.
    J Immunol Res. 2021;2021:6645885.
    PubMed    
    Abstract available

  21. MORGAN EL, Patterson MR, Barba-Moreno D, Scarth JA, et al
    The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01679.
    PubMed    
    Abstract available

  22. SONG L, Ding L, Feng MJ, Li XX, et al
    [Effects of hnRNP E1 on expression of early genes E2, E6 of HPV16 and biological function in cervical cancer cells].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42:321-326.
    PubMed    
    Abstract available

  23. FU Q, Xu Y, Zuo J, An J, et al
    Comparison of two inverse planning algorithms for cervical cancer brachytherapy.
    J Appl Clin Med Phys. 2021 Feb 24. doi: 10.1002/acm2.13195.
    PubMed    
    Abstract available

  24. BIZZARRI N, Pedone Anchora L, Ferrandina G, Scambia G, et al
    ASO Author Reflections: Conization Before Radical Hysterectomy Improves Disease-Free Survival in Early Stage Cervical Cancer.
    Ann Surg Oncol. 2021 Feb 24. pii: 10.1245/s10434-021-09697.
    PubMed    


  25. LI Z, Chen J, Zhao S, Li Y, et al
    Discovery and validation of novel biomarkers for detection of cervical cancer.
    Cancer Med. 2021 Feb 23. doi: 10.1002/cam4.3799.
    PubMed    
    Abstract available

  26. XU W, Xie S, Chen X, Pan S, et al
    Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
    Drug Des Devel Ther. 2021;15:577-588.
    PubMed    
    Abstract available

  27. PALAIA I, Tomao F, DI Pinto A, Pernazza A, et al
    Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.
    In Vivo. 2021;35:1277-1283.
    PubMed    
    Abstract available

  28. MUKAI Y, Yokota NR, Sugiura M, Mizushima T, et al
    Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases.
    In Vivo. 2021;35:1169-1176.
    PubMed    
    Abstract available

  29. CHUNG YK, Lee YK, Yoon BH, Suh DH, et al
    Pelvic Insufficiency Fractures in Cervical Cancer After Radiation Therapy: A Meta-Analysis and Review.
    In Vivo. 2021;35:1109-1115.
    PubMed    
    Abstract available

  30. ZHANG L, Wu X, Li Y, Teng X, et al
    LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
    Autoimmunity. 2021 Feb 23:1-9. doi: 10.1080/08916934.2020.1864731.
    PubMed    
    Abstract available

  31. MOISE RK, Jonas E, Campa EM, Clisbee M, et al
    Bayo Lapawol (Let Their Voices Be Heard): Haitian Women's Barriers to and Facilitators of Cervical Cancer Prevention and Control.
    Health Educ Behav. 2021 Feb 23:1090198121990381. doi: 10.1177/1090198121990381.
    PubMed    
    Abstract available

  32. SHEN X, Li L, He Y, Lv X, et al
    Raddeanin A inhibits proliferation, invasion, migration and promotes apoptosis of cervical cancer cells via regulating miR-224-3p/Slit2/Robo1 signaling pathway.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  33. KURIAN R, Kirchhoff-Rowald A, Sahil S, Cheng AL, et al
    The Risk of Primary Uterine and Cervical Cancer After Hysteropexy.
    Female Pelvic Med Reconstr Surg. 2021;27:e493-e496.
    PubMed    
    Abstract available

  34. BIZZARRI N, Pedone Anchora L, Kucukmetin A, Ratnavelu N, et al
    Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study.
    Ann Surg Oncol. 2021 Feb 23. pii: 10.1245/s10434-021-09695.
    PubMed    
    Abstract available

  35. GELDSETZER P, Lemp JM
    Cervical Cancer Screening in Low- and Middle-Income Countries-Reply.
    JAMA. 2021;325:790-791.
    PubMed    


  36. CREMER M, Alfaro K, Masch R
    Cervical Cancer Screening in Low- and Middle-Income Countries.
    JAMA. 2021;325:790.
    PubMed    


  37. DENG C, Ding D, Wang M
    The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB~IVA cervical cancer.
    Postgrad Med. 2021 Feb 23. doi: 10.1080/00325481.2021.1894823.
    PubMed    
    Abstract available

  38. MORCOS M, Viswanathan AN, Enger SA
    On the impact of absorbed dose specification, tissue heterogeneities and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75 and Yb-169 in conventional and intensity modulated brachytherapy for the treatment of cervical cancer.
    Med Phys. 2021 Feb 22. doi: 10.1002/mp.14802.
    PubMed    
    Abstract available

  39. XING Y, Chen L, Gu H, Yang C, et al
    Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Oncogene. 2021 Feb 22. pii: 10.1038/s41388-021-01693.
    PubMed    
    Abstract available

  40. SIMS TT, El Alam MB, Karpinets TV, Dorta-Estremera S, et al
    Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.
    Commun Biol. 2021;4:237.
    PubMed    
    Abstract available

  41. GUO C, Wang J, Wang Y, Qu X, et al
    Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study.
    Transl Oncol. 2021;14:101032.
    PubMed    
    Abstract available

  42. WU X, Wu L, Han J, Wu Y, et al
    Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial.
    Arch Gynecol Obstet. 2021 Feb 22. pii: 10.1007/s00404-021-06005.
    PubMed    
    Abstract available

  43. MA X, Wu Z, Zhang J, Shao X, et al
    Increased ADAM12 Expression Predicts Poor Prognosis in Cervical Cancer Patients before General Anesthesia.
    Clin Lab. 2021;67.
    PubMed    
    Abstract available

  44. JI M, Na N, Lin S
    Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
    Clin Lab. 2021;67.
    PubMed    
    Abstract available

  45. HAN HY, Mou JT, Jiang WP, Zhai XM, et al
    Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
    Biosci Rep. 2021 Feb 22. pii: 227898. doi: 10.1042/BSR20204394.
    PubMed    
    Abstract available

  46. GHISU GP
    [Importance of the Pap smear in the age of HPV testing].
    Ther Umsch. 2021;78:93-98.
    PubMed    
    Abstract available

  47. TANG X, Wen X, Li Z, Wen D, et al
    Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis.
    J Cell Physiol. 2020 Dec 7. doi: 10.1002/jcp.30210.
    PubMed    
    Abstract available

  48. MOUSAVI SZ, Poortahmasebi V, Mokhtari-Azad T, Shahmahmoodi S, et al
    The dysregulation of microarray gene expression in cervical cancer is associated with overexpression of a unique messenger RNA signature.
    Iran J Microbiol. 2020;12:629-635.
    PubMed    
    Abstract available

  49. ZHENG Q, Chen X, Han R, Zhu J, et al
    HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry.
    J Cancer. 2021;12:1722-1728.
    PubMed    
    Abstract available

  50. TAKAHASHI M, Sakai K, Iwasa N, Wada M, et al
    Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
    J Obstet Gynaecol Res. 2021 Feb 21. doi: 10.1111/jog.14713.
    PubMed    
    Abstract available

  51. TAGUCHI A, Nakajima Y, Furusawa A, Yoshino Y, et al
    High neutrophil-to-lymphocyte ratio is a predictor of short-term survival for patients with recurrent cervical cancer after radiation-based therapy.
    J Obstet Gynaecol Res. 2021 Feb 21. doi: 10.1111/jog.14712.
    PubMed    
    Abstract available

  52. ANTINYAN A, Bertoni M, Corazzini L
    Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia.
    Soc Sci Med. 2021;273:113739.
    PubMed    
    Abstract available

  53. GU H, Wen J
    Abnormal level of paxillin in cervical cancer cells is involved in tumor progression and invasion.
    Acta Biochim Pol. 2021 Feb 20. pii: 5379. doi: 10.18388/abp.2020_5379.
    PubMed    
    Abstract available

  54. O'FLYNN H, Ryan NAJ, Narine N, Shelton D, et al
    Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.
    Nat Commun. 2021;12:952.
    PubMed    
    Abstract available

  55. MA C, Huang Z, Wu Z, Di C, et al
    Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis.
    Life Sci. 2021;269:119098.
    PubMed    
    Abstract available

  56. XUE P, Tang C, Li Q, Li Y, et al
    Development and validation of an artificial intelligence system for grading colposcopic impressions and guiding biopsies.
    BMC Med. 2020;18:406.
    PubMed    
    Abstract available

  57. MAHALINGAM S, Sundaramurthi S, Krishnaraj B, Sistla SC, et al
    Radiation-induced sarcoma presenting as a gluteal abscess: a diagnostic and therapeutic challenge.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  58. ALMUSALAM L, Alghtani N, Alkushi A, Arabi H, et al
    Uterine cervix rhabdomyosarcoma: an uncommon entity in an adult patient.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  59. TAGHAVI K, Rohner E, Basu P, Low N, et al
    Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis.
    BMC Womens Health. 2020;20:253.
    PubMed    
    Abstract available

  60. KATERJI M, Filippova M, Wongworawat YC, Siddighi S, et al
    Oxidative stress markers in patient-derived non-cancerous cervical tissues and cells.
    Sci Rep. 2020;10:19044.
    PubMed    
    Abstract available

  61. KURMYSHKINA O, Kovchur P, Schegoleva L, Volkova T, et al
    Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  62. MORGAN EL, Macdonald A
    Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
    Viruses. 2020;12.
    PubMed    
    Abstract available

  63. HERNANDEZ N, Desroches B, Peden E, Satkunasivam R, et al
    Uretero-Iliac artery fistula: a rare cause of haematuria.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  64. CHEN J, Qiu J, Li F, Jiang X, et al
    HN1 promotes tumor associated lymphangiogenesis and lymph node metastasis via NF-kappaB signaling activation in cervical carcinoma.
    Biochem Biophys Res Commun. 2020;530:87-94.
    PubMed    
    Abstract available

  65. RUAN M, Cheng Q, Gong C, Cao Z, et al
    Development of a kind of RG108-Fluorescein conjugates for detection of DNA methyltransferase 1 (DNMT1) in living cells.
    Anal Biochem. 2020;607:113823.
    PubMed    
    Abstract available

  66. ZHANG H, Pradhan D, Wang T, Ashman D, et al
    Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital.
    Cancer Cytopathol. 2020;128:852-859.
    PubMed    
    Abstract available

  67. RAMIREZ-PALACIOS P, Chen A, Flores YN, Crespi CM, et al
    Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico.
    Cancer Cytopathol. 2020;128:715-724.
    PubMed    
    Abstract available

  68. CORDOVA-RIVAS S, Araujo-Huitrado JG, Rivera-Avalos E, Escalante-Garcia IL, et al
    Differential Proliferation Effect of the Newly Synthesized Valine, Tyrosine and Tryptophan-Naphthoquinones in Immortal and Tumorigenic Cervical Cell Lines.
    Molecules. 2020;25.
    PubMed    
    Abstract available

  69. AVELINO KYPS, Oliveira LS, Lucena-Silva N, de Melo CP, et al
    Metal-polymer hybrid nanomaterial for impedimetric detection of human papillomavirus in cervical specimens.
    J Pharm Biomed Anal. 2020;185:113249.
    PubMed    
    Abstract available

  70. MURENZI G, Kanyabwisha F, Murangwa A, Kubwimana G, et al
    Twelve-year trend in the prevalence of high-risk human papillomavirus infection among Rwandan women living with HIV.
    J Infect Dis. 2020 Feb 12. pii: 5734756. doi: 10.1093.
    PubMed    
    Abstract available

  71. CHUA GT, Ho FK, Tung KT, Wong RS, et al
    Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females.
    Vaccine. 2019 Nov 27. pii: S0264-410X(19)31573.
    PubMed    
    Abstract available

  72. HE M, Wang Y, Cai J, Xie Y, et al
    LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway.
    Exp Cell Res. 2021 Mar 3:112551. doi: 10.1016/j.yexcr.2021.112551.
    PubMed    
    Abstract available

  73. ZHU Y, Ren C, Jiang D, Yang L, et al
    RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
    Cancer Sci. 2021 Mar 6. doi: 10.1111/cas.14874.
    PubMed    
    Abstract available

  74. TORNE A, Pahisa J, Ordi J, Fuste P, et al
    Oncological Results of Laparoscopically Assisted Radical Vaginal Hysterectomy in Early-Stage Cervical Cancer: Should We Really Abandon Minimally Invasive Surgery?
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  75. WANG Q, Vattai A, Vilsmaier T, Kaltofen T, et al
    Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  76. DA MATA S, Ferreira J, Nicolas I, Esteves S, et al
    P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  77. DEMING AC, Wellehan JFX, Colegrove KM, Hall A, et al
    Unlocking the Role of a Genital Herpesvirus, Otarine Herpesvirus 1, in California Sea Lion Cervical Cancer.
    Animals (Basel). 2021;11.
    PubMed    
    Abstract available

  78. JOHNSON CJ, Morawski BM, Hobbs L, Lewis D, et al
    Time from breast cancer diagnosis to treatment among Idaho's National Breast and Cervical Cancer Early Detection Program population, 2011-2017.
    Cancer Causes Control. 2021 Mar 4. pii: 10.1007/s10552-021-01407.
    PubMed    
    Abstract available

  79. XU Y, Luo H, Hu Q, Zhu H, et al
    Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
    Front Genet. 2021;12:598304.
    PubMed    
    Abstract available

  80. NAGELHOUT G, Ebisch RM, Van Der Hel O, Meerkerk GJ, et al
    Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis.
    Expert Rev Anticancer Ther. 2021 Mar 5:1-14. doi: 10.1080/14737140.2021.1888719.
    PubMed    
    Abstract available

  81. CHEN J, Cao YJ, Zhu L, Zhang BL, et al
    [Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2021;101:597-601.
    PubMed    
    Abstract available

  82. CHUAI Y, Rizzuto I, Zhang X, Li Y, et al
    Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
    Cochrane Database Syst Rev. 2021;3:CD013348.
    PubMed    
    Abstract available

  83. ZHU J, Han S
    Downregulation of LncRNA DARS-AS1 Inhibits the Tumorigenesis of Cervical Cancer via Inhibition of IGF2BP3.
    Onco Targets Ther. 2021;14:1331-1340.
    PubMed    
    Abstract available

  84. PKHAKADZE G, Bokhua Z, Asatiani T, Muzashvili T, et al
    STEM CELL INDEX IN THE PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA.
    Georgian Med News. 2021;:157-164.
    PubMed    
    Abstract available

  85. WANG Q, Yen YT, Xie C, Liu F, et al
    Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
    Drug Deliv. 2021;28:510-519.
    PubMed    
    Abstract available

  86. FAN WJ, Ding H, Chen XX, Yang L, et al
    All-Trans Retinoic Acid Potentiates Antitumor Efficacy of Cisplatin by Increasing Differentiation of Cancer Stem-Like Cells in Cervical Cancer.
    Ann Clin Lab Sci. 2021;51:22-29.
    PubMed    
    Abstract available

  87. XIA C, Xu X, Zhao X, Hu S, et al
    Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.
    BMC Med. 2021;19:62.
    PubMed    
    Abstract available

  88. AKWIDITYA MA, Yong CY, Yusof MT, Mariatulqabtiah AR, et al
    Hepatitis B Virus-Like Particle: Targeted Delivery of Plasmid Expressing Short Hairpin RNA for Silencing the Bcl-2 Gene in Cervical Cancer Cells.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  89. WANG J, Wu Y, Li Y, Wang Y, et al
    Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
    Int J Oncol. 2021;58:1.
    PubMed    
    Abstract available

  90. SHAO X, Zheng X, Ma D, Liu Y, et al
    Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Biosci Rep. 2021 Mar 1. pii: 227998. doi: 10.1042/BSR20200533.
    PubMed    
    Abstract available

  91. ZHANG J, Rashmi R, Inkman M, Jayachandran K, et al
    Integrating imaging and RNA-seq improves outcome prediction in cervical cancer.
    J Clin Invest. 2021;131.
    PubMed    
    Abstract available

  92. HU Q, Ke G
    Intravesical Instillation of Kangfuxin Liquid Combined with Thrombin and Epidermal Growth Factor for Radiation-induced Hemorrhagic Cystitis in Patients with Cervical Cancer: A report of 34 cases.
    Bioengineered. 2021;12:815-820.
    PubMed    
    Abstract available

  93. MOUSAVI AS, Pouryasin A, Yarandi F, Pirzadeh L, et al
    Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women.
    Iran J Public Health. 2020;49:1734-1742.
    PubMed    
    Abstract available

  94. PUSPITASARI IM, Legianawati D, Sinuraya RK, Suwantika AA, et al
    Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients.
    Int J Womens Health. 2021;13:221-229.
    PubMed    
    Abstract available

  95. KATANYOO K, Thavaramara T
    Clinical Impact of Pelvic Lymph Node Status in Locally Advanced Cervical Cancer Patients Treated by Concurrent Chemoradiation Therapy.
    Asian Pac J Cancer Prev. 2021;22:491-497.
    PubMed    
    Abstract available

  96. JOSHI S, Muwonge R, Kulkarni V, Lucas E, et al
    Mobile Screening Unit (MSU) for the Implementation of the 'Screen and Treat' Programme for Cervical Cancer Prevention In Pune, India.
    Asian Pac J Cancer Prev. 2021;22:413-418.
    PubMed    
    Abstract available

  97. SOLDEVILA-LOZANO C, Sabate-Llobera A, Robles-Barba JJ, Mestres-Marti J, et al
    Mediastinal Recurrence of Uterine Cervix Cancer on 18F-FDG PET/CT.
    Clin Nucl Med. 2021 Jan 19. pii: 00003072-900000000-96246.
    PubMed    
    Abstract available

  98. VAHABI M, Lofters AK, Kopp A, Glazier RH, et al
    Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
    Cancer Causes Control. 2021;32:147-155.
    PubMed    
    Abstract available

  99. MACDONALD EJ, Geller S, Sibanda N, Stevenson K, et al
    Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
    Aust N Z J Obstet Gynaecol. 2021;61:135-141.
    PubMed    
    Abstract available

  100. SITARESMI MN, Rozanti NM, Simangunsong LB, Wahab A, et al
    Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
    BMC Public Health. 2020;20:1836.
    PubMed    
    Abstract available

  101. TUGWELL P, Andre Knottnerus J
    Cervical screening and overdiagnosis: continuation of Controversy and Debate.
    J Clin Epidemiol. 2020;127:A8-A10.
    PubMed    


  102. KNOTTNERUS JA, Tugwell P
    Editors Epilogue; Looking back and forward in the arena of screening, overdiagnosis, and optimizing outcome: editors' epilogue.
    J Clin Epidemiol. 2020;127:244-245.
    PubMed    


  103. CHALMERS I
    Response to above Commentaries and Letters by defenders of the inquiry into the management of cervical carcinoma in situ in National Women's Hospital, New Zealand, in the 1960s and early 1970s.
    J Clin Epidemiol. 2020;127:241-243.
    PubMed    


  104. RAFFLE AE, Gray JAM
    Response to above Commentaries and Letters by the authors of "The 1960s cervical screening incident at National Women's Hospital, Auckland, New Zealand: insights for screening research, policy making, and practice".
    J Clin Epidemiol. 2020;127:237-240.
    PubMed    


  105. SKEGG DCG
    Letter to the editor: The 1960s cervical screening incident at National Women's Hospital, Auckland, New Zealand.
    J Clin Epidemiol. 2020;127:235-236.
    PubMed    


  106. JONES RW
    Letter to the editor: A clinician's perspective of the 'unfortunate experiment'.
    J Clin Epidemiol. 2020;127:229-230.
    PubMed    


  107. WELLER DP, Elfstrom KM
    Commentary: Back to the future in cervical screening: applying a contemporary lens to an old controversy.
    J Clin Epidemiol. 2020;127:218-219.
    PubMed    


  108. MURAKAMI T, Takasawa A, Takasawa K, Akimoto T, et al
    Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
    Cancer Sci. 2021;112:906-917.
    PubMed    
    Abstract available

  109. IKEDA S, Ueda Y, Hara M, Yagi A, et al
    Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study.
    Cancer Sci. 2021;112:839-846.
    PubMed    
    Abstract available

  110. TAGHINEZHAD-S S, Keyvani H, Bermudez-Humaran LG, Donders GGG, et al
    Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis.
    Cell Mol Life Sci. 2021;78:1191-1206.
    PubMed    
    Abstract available

  111. PEARLMAN PC
    Promise of Smartphone-Enabled Teleconsultation for Global Cancer Prevention.
    JCO Glob Oncol. 2020;6:1389-1391.
    PubMed    


  112. GILHAM C
    Implications for women testing positive for human papillomavirus.
    BJOG. 2021;128:755.
    PubMed    


  113. COSTA PA, Needelman BS, Tjendra Y, Hoffman JE, et al
    High-grade B-cell lymphoma with MYC and BCL6 rearrangements presenting as a cervical mass.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  114. BENNETT KF, Waller J, McBride E, Forster AS, et al
    Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
    BJOG. 2021;128:745-754.
    PubMed    
    Abstract available

  115. MATSUURA Y, Noguchi A, Sakai S, Yokota N, et al
    Nuclear accumulation of ZFP36L1 is cell cycle-dependent and determined by a C-terminal serine-rich cluster.
    J Biochem. 2020;168:477-489.
    PubMed    
    Abstract available

  116. WILLYSSON A, Stahl AL, Gillet D, Barbier J, et al
    Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit.
    Toxins (Basel). 2020;12.
    PubMed    
    Abstract available

  117. SINGH G, Nenavathu BP, Imtiyaz K, Moshahid A Rizvi M, et al
    Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
    Biomed Pharmacother. 2020;129:110443.
    PubMed    
    Abstract available

  118. XU H, Wang L, Shi B, Hu L, et al
    Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of alpha-tubulin acetylation.
    Biomed Pharmacother. 2020;129:110441.
    PubMed    
    Abstract available

  119. FAVELA-BUENO J, Perez-Morales R, Ramirez-Torres J, Hernandez-Arteaga L, et al
    Identification of Multiple High-Risk Human Papillomavirus Infections in a Rural Population of Canatlan, Durango, Mexico.
    Genet Test Mol Biomarkers. 2020;24:370-374.
    PubMed    
    Abstract available

  120. HOLUBEKOVA V, Mersakova S, Grendar M, Snahnicanova Z, et al
    The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia.
    Genet Test Mol Biomarkers. 2020;24:256-263.
    PubMed    
    Abstract available

  121. BAYRAMOGLU TEPE N, Ozcorekci O
    Knowledge about the human papillomavirus among high school and university students a comprehensive questionnaire study from Southeast Turkey.
    J Obstet Gynaecol Res. 2020;46:907-916.
    PubMed    
    Abstract available

  122. SONG YC, Huang HC, Chang CY, Lee HJ, et al
    A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses.
    Front Immunol. 2020;11:62.
    PubMed    
    Abstract available

  123. MEHRA N, Christopher V, Dhanushkodi M, Radhakrishnan V, et al
    A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.
    Int J Clin Pharm. 2020;42:662-666.
    PubMed    
    Abstract available

  124. SHYAMSIVAPPAN S, Vivek R, Saravanan A, Arasakumar T, et al
    A novel 8-nitro quinoline-thiosemicarbazone analogues induces G1/S & G2/M phase cell cycle arrest and apoptosis through ROS mediated mitochondrial pathway.
    Bioorg Chem. 2020;97:103709.
    PubMed    
    Abstract available

  125. OZCAN Z, Kimiloglu E, Igdem AA, Erdogan N, et al
    Comparison of the Diagnostic Utility of Manual Screening and the ThinPrep Imaging System in Liquid-Based Cervical Cytology.
    Turk Patoloji Derg. 2020;36:135-141.
    PubMed    
    Abstract available

  126. YUE Z, Ding S, Zhao W, Wang H, et al
    Automatic CIN Grades Prediction of Sequential Cervigram Image Using LSTM With Multistate CNN Features.
    IEEE J Biomed Health Inform. 2020;24:844-854.
    PubMed    
    Abstract available

  127. DU J, Song D, Li J, Li Y, et al
    Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway.
    Psychopharmacology (Berl). 2021 Mar 12. pii: 10.1007/s00213-021-05811.
    PubMed    
    Abstract available

  128. LI R, Zhang Y, Ma B, Tan K, et al
    Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
    Ann Transl Med. 2021;9:239.
    PubMed    
    Abstract available

  129. FARZANEHPOUR M, Faghihloo E, Salimi V, Jalilvand S, et al
    Comparison of Snail1, ZEB1, E-Cadherin Expression Levels in HPV-Induced Cervical Cancer.
    Iran J Public Health. 2020;49:2179-2188.
    PubMed    
    Abstract available

  130. JIANG L, Li B, Zhang Y, Ma S, et al
    Influence of Pelvic Intensity-Modulated Radiation Therapy With Concurrent Cisplatin-Based Chemotherapy of Cervical Cancer on the Vaginal Microbiome.
    Front Oncol. 2021;11:615439.
    PubMed    
    Abstract available

  131. CASTELLI S, Ciccarone F, Tavian D, Ciriolo MR, et al
    ROS-dependent HIF1alpha activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells.
    J Exp Clin Cancer Res. 2021;40:94.
    PubMed    
    Abstract available

  132. ZIVARPOUR P, Nikkhah E, Maleki Dana P, Asemi Z, et al
    Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer.
    J Ovarian Res. 2021;14:43.
    PubMed    
    Abstract available

  133. MWALIKO E, Van Hal G, Bastiaens H, Van Dongen S, et al
    Early detection of cervical cancer in western Kenya: determinants of healthcare providers performing a gynaecological examination for abnormal vaginal discharge or bleeding.
    BMC Fam Pract. 2021;22:52.
    PubMed    
    Abstract available

  134. SHRIVASTAVA A, Mishra SP, Pradhan S, Choudhary S, et al
    An Assessment of Serum Oxidative Stress and Antioxidant Parameters in Patients Undergoing Treatment for Cervical Cancer.
    Free Radic Biol Med. 2021 Mar 8. pii: S0891-5849(21)00135.
    PubMed    
    Abstract available

  135. WANG Y, Shen N, Li S, Yu H, et al
    Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.
    Nano Lett. 2021 Mar 11. doi: 10.1021/acs.nanolett.0c04402.
    PubMed    
    Abstract available

  136. WANG Y, He M, Zhang G, Cao K, et al
    The immune landscape during the tumorigenesis of cervical cancer.
    Cancer Med. 2021 Mar 10. doi: 10.1002/cam4.3833.
    PubMed    
    Abstract available

  137. SALAVATIHA Z, Farahmand M, Shoja Z, Jalilvand S, et al
    A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.
    J Med Virol. 2021 Mar 10. doi: 10.1002/jmv.26928.
    PubMed    
    Abstract available

  138. LIU X, Feng Q, Zhang Y, Zheng P, et al
    Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial-mesenchymal transition.
    Cancer Cell Int. 2021;21:163.
    PubMed    
    Abstract available

  139. AHMAD A, Tiwari RK, Saeed M, Ahmad I, et al
    Glycyrrhizin Mediates Downregulation of Notch Pathway Resulting in Initiation of Apoptosis and Disruption in the Cell Cycle Progression in Cervical Cancer Cells.
    Nutr Cancer. 2021 Mar 10:1-18. doi: 10.1080/01635581.2021.1895234.
    PubMed    
    Abstract available

  140. HARUYAMA R, Obara H, Fujita N
    What is the current status of Japan's efforts to meet global goals and targets to eliminate cervical cancer?
    Glob Health Med. 2021;3:44-47.
    PubMed    
    Abstract available

  141. CHA EY, Chun H
    Barriers and Challenges to Cervical Cancer Screening, Follow-Up, and Prevention Measures among Korean Immigrant Women in Hawaii.
    Asia Pac J Oncol Nurs. 2021;8:132-138.
    PubMed    
    Abstract available

  142. DUAN Y, Bai H, Li X, Wang D, et al
    Oncolytic adenoviral H101 synergizes with radiation in cervical cancer cells.
    Curr Cancer Drug Targets. 2021 Mar 7. pii: CCDT-EPUB-114753.
    PubMed    
    Abstract available

  143. ZHAO J, Li H, Yuan M
    EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
    Genes Genomics. 2021 Mar 9. pii: 10.1007/s13258-021-01064.
    PubMed    
    Abstract available

  144. KUEHN BM
    Dramatic Cervical Cancer Screening Decline During Pandemic.
    JAMA. 2021;325:925.
    PubMed    


  145. BUDAK A, Budak E, Kanmaz AG, Inan AH, et al
    Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer.
    Q J Nucl Med Mol Imaging. 2021 Mar 9. pii: S1824-4785.21.03324.
    PubMed    
    Abstract available

  146. MAO D, Cao H, Shi M, Wang CC, et al
    Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
    EBioMedicine. 2021;65:103242.
    PubMed    
    Abstract available

  147. WANG J, Zhang C
    Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer.
    Bioengineered. 2021;12:898-913.
    PubMed    
    Abstract available

  148. CAO X, Che X
    The effect of different doses of Dexmetomidine anesthesia on the recovery time of laparoscopic surgery for cervical cancer.
    Minerva Med. 2021 Mar 8. pii: S0026-4806.21.07344.
    PubMed    


  149. FAVRE G, Guani B, Balaya V, Magaud L, et al
    Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.
    Front Oncol. 2021;10:621518.
    PubMed    
    Abstract available

  150. QU HD, Han DM, Zhang N, Mao Z, et al
    Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
    Front Oncol. 2021;10:621347.
    PubMed    
    Abstract available

  151. XING B, Guo J, Sheng Y, Wu G, et al
    Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.
    Front Oncol. 2021;10:606335.
    PubMed    
    Abstract available

  152. BRAVO-CUELLAR A, Ortiz-Lazareno PC, Sierra-Diaz E, Solorzano-Ibarra F, et al
    Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways.
    Front Oncol. 2020;10:592706.
    PubMed    
    Abstract available

  153. AITKEN CA, Kaljouw S, Siebers AG, Bron M, et al
    sInvestigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics.
    Prev Med Rep. 2021;22:101328.
    PubMed    
    Abstract available

  154. SONODA K, Ohgami T, Hachisuga M, Fujita Y, et al
    Difficulty of cervical cancer diagnosis during pregnancy: A case series analysis of the clinicopathological characteristics and prognosis of cervical cancer diagnosed during pregnancy or within 6 months after parturition.
    Mol Clin Oncol. 2021;14:67.
    PubMed    
    Abstract available

  155. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Anticipated help seeking behaviour and barriers to seeking care for possible breast and cervical cancer symptoms in Uganda and South Africa.
    Ecancermedicalscience. 2021;15:1171.
    PubMed    
    Abstract available

  156. SHI X, Deng Z, Wang S, Zhao S, et al
    Increased HSF1 Promotes Infiltration and Metastasis in Cervical Cancer via Enhancing MTDH-VEGF-C Expression.
    Onco Targets Ther. 2021;14:1305-1315.
    PubMed    
    Abstract available

  157. WANG T, Zhang XD, Hua KQ
    A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
    Taiwan J Obstet Gynecol. 2021;60:253-261.
    PubMed    
    Abstract available

  158. PORTNOY A, Pedersen K, Trogstad L, Hansen BT, et al
    Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.
    Prev Med. 2021;144:106276.
    PubMed    
    Abstract available

  159. CAMPOS NG, Demarco M, Bruni L, Desai KT, et al
    A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.
    Prev Med. 2021;144:106438.
    PubMed    
    Abstract available

  160. OLIVEIRA CR, Niccolai LM
    Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination.
    Prev Med. 2021;144:106363.
    PubMed    
    Abstract available

  161. ORTIZ AP, Soto-Salgado M, Calo WA, Hull P, et al
    Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study.
    Prev Med. 2021;144:106336.
    PubMed    
    Abstract available

  162. HINMAN AR, Orenstein WA
    Elimination of cervical cancer: Lessons learned from polio and earlier eradication programs.
    Prev Med. 2021;144:106325.
    PubMed    
    Abstract available

  163. GRAVITT PE, Silver MI, Hussey HM, Arrossi S, et al
    Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach.
    Prev Med. 2021;144:106322.
    PubMed    
    Abstract available

  164. WHOP LJ, Smith MA, Butler TL, Adcock A, et al
    Achieving cervical cancer elimination among Indigenous women.
    Prev Med. 2021;144:106314.
    PubMed    
    Abstract available

  165. TORODE J, Kithaka B, Chowdhury R, Simelela N, et al
    National action towards a world free of cervical cancer for all women.
    Prev Med. 2021;144:106313.
    PubMed    


  166. GODFREY C, Prainito A, Lapidos-Salaiz I, Barnhart M, et al
    Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership.
    Prev Med. 2021;144:106295.
    PubMed    
    Abstract available

  167. GIULIANO AR, Niccolai LM
    A world without cervical cancer is within our reach.
    Prev Med. 2021;144:106462.
    PubMed    


  168. PINEROS M, Saraiya M, Baussano I, Bonjour M, et al
    The role and utility of population-based cancer registries in cervical cancer surveillance and control.
    Prev Med. 2021;144:106237.
    PubMed    
    Abstract available

  169. CARRERO YN, Callejas DE, Mosquera JA
    In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review.
    Transl Oncol. 2021;14:101058.
    PubMed    
    Abstract available

  170. WAN HY, Li QQ, Zhang Y, Tian W, et al
    Corrigendum to "MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells" [Cancer Letters 355 (2014) 148-158].
    Cancer Lett. 2021 Mar 3. pii: S0304-3835(21)00087.
    PubMed    


  171. LIU YY, Guo RX, Li BJ, Wu Y, et al
    [Analysis of clinical features of cervical precancerous lesions in postmenopausal women].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:114-120.
    PubMed    
    Abstract available

  172. WANG Z, Kang Y, Yu F, Zhong FH, et al
    TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the COVID-19 pandemic.
    Future Oncol. 2021;17:1197-1207.
    PubMed    
    Abstract available

  173. IEZZONI LI, Rao SR, Agaronnik ND, El-Jawahri A, et al
    Associations Between Disability and Breast or Cervical Cancers, Accounting for Screening Disparities.
    Med Care. 2021;59:139-147.
    PubMed    
    Abstract available

  174. SONG M, Lin J, Song F, Wu D, et al
    The value of MR-based radiomics in identifying residual disease in patients with carcinoma in situ after cervical conization.
    Sci Rep. 2020;10:19890.
    PubMed    
    Abstract available

  175. REHEMAN D, Zhao J, Guan S, Xu GC, et al
    Apoptotic effect of novel pyrazolone-based derivative [Cu(PMPP-SAL)(EtOH)] on HeLa cells and its mechanism.
    Sci Rep. 2020;10:18235.
    PubMed    
    Abstract available

  176. XU J, Zou J, Wu L, Lu W, et al
    Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma.
    Sci Rep. 2020;10:16584.
    PubMed    
    Abstract available

  177. ASIEDU MN, Agudogo JS, Dotson ME, Skerrett E, et al
    A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system.
    Sci Rep. 2020;10:16570.
    PubMed    
    Abstract available

  178. WU Y, Wang X, Meng L, Li W, et al
    Changes of miRNA Expression Profiles from Cervical-Vaginal Fluid-Derived Exosomes in Response to HPV16 Infection.
    Biomed Res Int. 2020;2020:7046894.
    PubMed    
    Abstract available

  179. BARQUET-MUNOZ SA, Cantu-de-Leon D, Bandala-Jacques A, Gonzalez-Enciso A, et al
    What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
    World J Surg Oncol. 2020;18:101.
    PubMed    
    Abstract available

  180. ROSENDO-CHALMA P, Antonio-Vejar V, Bigoni-Ordonez GD, Patino-Morales CC, et al
    CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
    Int J Oncol. 2020;57:301-313.
    PubMed    
    Abstract available

  181. ZHANG X, Liu CR, Wang ZZ, Ren ZF, et al
    Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study.
    Vaccine. 2020;38:3665-3670.
    PubMed    
    Abstract available

  182. BAE JK, Roh HJ, You JS, Kim K, et al
    Quantitative Screening of Cervical Cancers for Low-Resource Settings: Pilot Study of Smartphone-Based Endoscopic Visual Inspection After Acetic Acid Using Machine Learning Techniques.
    JMIR Mhealth Uhealth. 2020;8:e16467.
    PubMed    
    Abstract available

  183. LERAY H, Gabiache E, Courbon F, Brenot-Rossi I, et al
    FDG-PET/CT identifies predictors of survival in patients with locally advanced cervical carcinoma and para-aortic lymph node involvement to increase treatment.
    J Nucl Med. 2020 Feb 7. pii: jnumed.119.238824. doi: 10.2967/jnumed.119.238824.
    PubMed    
    Abstract available

  184. WANG J, Zhu Z, Qiu H, Liu C, et al
    LncRNA NKILA inhibits the proliferation and promotes the apoptosis of CSCC cells by downregulating miRNA-21.
    J Cell Physiol. 2020;235:7863-7869.
    PubMed    
    Abstract available

  185. ANWARI P, Debellut F, Vodicka E, Clark A, et al
    Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan.
    Vaccine. 2019 Dec 20. pii: S0264-410X(19)31655.
    PubMed    
    Abstract available

  186. ZHAO J, Zhu J, Guo J, Zhu T, et al
    Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
    J Med Virol. 2020;92:372-381.
    PubMed    
    Abstract available

  187. KAZAN HH, Urfali-Mamatoglu C, Yalcin GD, Bulut O, et al
    15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin.
    J Cell Physiol. 2020;235:4965-4978.
    PubMed    
    Abstract available

  188. ZHANG S, Saito M, Yamada S, Sakamoto J, et al
    The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.
    J Med Virol. 2020;92:364-371.
    PubMed    
    Abstract available

  189. PESIC A, Krings A, Hempel M, Preyer R, et al
    Clinical performance of the HPV DNA Array genotyping assay in detection of CIN2+ lesions with BS GP5+/6+ MPG Luminex tested cervical samples.
    J Med Virol. 2020;92:113-118.
    PubMed    
    Abstract available

  190. LV F, Zhong Y, Sang L, Wu X, et al
    MiR-1179 is downregulated in cervical cancer and its overexpression suppresses cancer cells invasion by targeting CHAF1A/ZEB1.
    Acta Biochim Pol. 2021 Mar 19. pii: 5499. doi: 10.18388/abp.2020_5499.
    PubMed    
    Abstract available

  191. KIMONDO FC, Kajoka HD, Mwantake MR, Amour C, et al
    Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
    Cancer Rep (Hoboken). 2021 Mar 19:e1374. doi: 10.1002/cnr2.1374.
    PubMed    
    Abstract available

  192. JANKOVIC S, Zivkovic Zaric R, Krasic K, Opancina V, et al
    New instrument for measuring quality of life in patients with cervical cancer.
    Health Care Women Int. 2021 Mar 19:1-15. doi: 10.1080/07399332.2021.1878174.
    PubMed    
    Abstract available

  193. YANG Y, Han A, Wang X, Yin X, et al
    Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.
    J Cell Mol Med. 2021 Mar 18. doi: 10.1111/jcmm.16461.
    PubMed    
    Abstract available

  194. GRAVDAL BH, Lonnberg S, Skare GB, Sulo G, et al
    Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
    BMC Womens Health. 2021;21:110.
    PubMed    
    Abstract available

  195. WANG Z, Ren C, Yang L, Zhang X, et al
    Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  196. GU Q, Hou W, Shi L, Liu H, et al
    Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression.
    Bioengineered. 2021;12:927-936.
    PubMed    
    Abstract available

  197. VENGALOOR THOMAS T, Gandhi S, Bhanat E, Krishna K, et al
    An Analysis of the Racial Disparities Among Cervical Cancer Patients Treated at an Academic Medical Center in the Southeastern United States.
    Cureus. 2021;13:e13296.
    PubMed    
    Abstract available

  198. LIANG LJ, Yang Y, Wei WF, Wu XG, et al
    Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression.
    Oncogenesis. 2021;10:30.
    PubMed    
    Abstract available

  199. XU S, Wang X, Yang Y, Li Y, et al
    LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer.
    Cell Death Dis. 2021;12:282.
    PubMed    
    Abstract available

  200. BURGER EA, Jansen EE, Killen J, Kok IM, et al
    Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
    J Med Screen. 2021 Mar 17:9691413211001097. doi: 10.1177/09691413211001097.
    PubMed    
    Abstract available

  201. CHEN W
    [New research progress of the safety of human papillomavirus vaccine].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55:428-434.
    PubMed    
    Abstract available

  202. SUN W, Li J, Yang ZY, Zheng YD, et al
    [The research progress of circular RNAs in the development and progression of cervical cancer].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55:409-412.
    PubMed    
    Abstract available

  203. CHIVA L, Chacon E
    Is Conization a Protective Surgical Maneuver in Early Cervical Cancer?
    Ann Surg Oncol. 2021 Mar 17. pii: 10.1245/s10434-021-09705.
    PubMed    


  204. HOLMSTROM O, Linder N, Kaingu H, Mbuuko N, et al
    Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.
    JAMA Netw Open. 2021;4:e211740.
    PubMed    
    Abstract available

  205. SONG TF, Xu AL, Chen XH, Gao JY, et al
    Circular RNA circRNA_101996 promoted cervical cancer development by regulating miR-1236-3p/TRIM37 axis.
    Kaohsiung J Med Sci. 2021 Mar 17. doi: 10.1002/kjm2.12378.
    PubMed    
    Abstract available

  206. CHEN Z, Ling K, Zhu Y, Deng L, et al
    circ0000069 promotes cervical cancer cell proliferation and migration by inhibiting miR-4426.
    Biochem Biophys Res Commun. 2021;551:114-120.
    PubMed    
    Abstract available

  207. MARIE TEBEU P, Saint Saba Antaon J, Adjeba M, Pikop F, et al
    [Knowledge, attitudes and practices of health professionals regard to cervical cancer in Cameroon].
    Sante Publique. 2020;32:489-496.
    PubMed    
    Abstract available

  208. GONG SJ, Shim SJ
    Successful treatment results of external radiotherapy without brachytherapy in advanced uterine cervical cancer.
    J Cancer Res Ther. 2021;17:255-257.
    PubMed    
    Abstract available

  209. KUMAR A, Tudu R, Singh R, Raina P, et al
    Dose-volume analysis of acute gastrointestinal complications in cervical cancer undergoing definitive concurrent chemoradiation.
    J Cancer Res Ther. 2021;17:170-173.
    PubMed    
    Abstract available

  210. TIAN T, Dong Y, Zhu Y, Chen Y, et al
    Hypoxia-induced CNPY2 upregulation promotes glycolysis in cervical cancer through activation of AKT pathway.
    Biochem Biophys Res Commun. 2021;551:63-70.
    PubMed    
    Abstract available

  211. YU EY, Zhao RY, Wang DS
    Inhibitory effect of Aphidicolin - a tetracyclic diterpene - on the proliferation and apoptotic induction in human cervical cancer (HeLa) cells.
    J BUON. 2021;26:291.
    PubMed    
    Abstract available

  212. CHEN H, Feng X, Gao L, Mickymaray S, et al
    Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells.
    Artif Cells Nanomed Biotechnol. 2021;49:240-249.
    PubMed    
    Abstract available

  213. KOVACHEV SM, Kovachev MS
    The role of perioperative ureteral stenting for urologic complications in radical surgery of cervical cancer.
    Urologia. 2021 Mar 14:3915603211001178. doi: 10.1177/03915603211001178.
    PubMed    
    Abstract available

  214. YOUNES S, Kaufmann AM, Hafner N, Beer K, et al
    Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer.
    Cancer Rep (Hoboken). 2021 Mar 14:e1366. doi: 10.1002/cnr2.1366.
    PubMed    
    Abstract available

  215. LEI C, Huang M, Li N, An J, et al
    Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys.
    Gynecol Oncol Rep. 2021;36:100724.
    PubMed    
    Abstract available

  216. HUANG Y, Tian Y, Zhang W, Liu R, et al
    Rab12 Promotes Radioresistance of HPV-Positive Cervical Cancer Cells by Increasing G2/M Arrest.
    Front Oncol. 2021;11:586771.
    PubMed    
    Abstract available

  217. TAWE L, Grover S, Zetola N, Robertson ES, et al
    Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana.
    Front Oncol. 2021;11:560296.
    PubMed    
    Abstract available

  218. WANG A, Xu Q, Sha R, Bao T, et al
    MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.
    Oncol Lett. 2021;21:272.
    PubMed    
    Abstract available

  219. LAIOS A, Duarte Portela S, Papadopoulou A, Gallos ID, et al
    Ovarian transposition and cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021 Feb 26. pii: S1521-6934(21)00037.
    PubMed    
    Abstract available

  220. AKGUN AKTAS B, Toptas T, Ureyen I, Dogan S, et al
    Obstetrician-gynecologists' practice patterns regarding HPV testing in cervical cancer screening in Turkey.
    Turk J Obstet Gynecol. 2021;18:15-22.
    PubMed    
    Abstract available

  221. AFFAR S, Morrison DS, Campbell C
    Cervical cancer incidence by ethnic group in Scotland from 2008 to 2017: A population-based study.
    Eur J Cancer Care (Engl). 2021 Mar 14:e13441. doi: 10.1111/ecc.13441.
    PubMed    
    Abstract available

  222. MISHRA N, Mishra S
    Exendin-4 - A potential therapeutic for type 2 diabetes-linked cervical cancer?
    EBioMedicine. 2021;65:103273.
    PubMed    


  223. AZAR D, Murphy M, Fishman A, Sewell L, et al
    Barriers and facilitators to participation in breast, bowel and cervical cancer screening in rural Victoria: a qualitative study.
    Health Promot J Austr. 2021 Mar 13. doi: 10.1002.
    PubMed    
    Abstract available

  224. LEE J, Lin JB, Wu MH, Chang CL, et al
    Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer.
    Support Care Cancer. 2021 Mar 12. pii: 10.1007/s00520-021-06131.
    PubMed    
    Abstract available

  225. NI M, Li J, Zhao H, Xu F, et al
    BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
    Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01735.
    PubMed    
    Abstract available

  226. SIMJAK P, Parizek A, Slama J
    Prenatal care for woman after fertility-sparing surgery for cervical cancer.
    Ceska Gynekol. 2020;85:422-429.
    PubMed    
    Abstract available

  227. SLAMA J, Dvorak V, Trnkova M, Skrivanek A, et al
    Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
    Ceska Gynekol. 2020;85:368-374.
    PubMed    
    Abstract available

  228. KASAVEN LS, Jones BP, Keays R, Saso S, et al
    Anaesthetic considerations for fertility-sparing surgery and uterine transplantation.
    Anaesthesia. 2021;76 Suppl 4:46-55.
    PubMed    
    Abstract available

  229. WOO YL, Gravitt P, Khor SK, Ng CW, et al
    Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era.
    Prev Med. 2021;144:106294.
    PubMed    
    Abstract available

  230. MOTAZE NV, Chi PC, Ongolo-Zogo P, Ndongo JS, et al
    Government regulation of private health insurance.
    Cochrane Database Syst Rev. 2021;2:CD011512.
    PubMed    
    Abstract available

  231. SMOLARCZYK K, Pieta W, Majewski S
    Assessment of the State of Knowledge about HPV Infection and HPV Vaccination among Polish Resident Doctors.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  232. DU J, Ahrlund-Richter A, Nasman A, Dalianis T, et al
    Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
    Arch Gynecol Obstet. 2021;303:329-335.
    PubMed    
    Abstract available

  233. MAJOR AL, Dvorak V, Schwarzova J, Skrivanek A, et al
    Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.
    Arch Gynecol Obstet. 2021;303:501-511.
    PubMed    
    Abstract available

  234. NASIOUDIS D, Albright B, Haggerty AF, Ko EM, et al
    Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size less than or equal to 2 cm.
    Am J Obstet Gynecol. 2020 Oct 28. pii: S0002-9378(20)31274.
    PubMed    


  235. LONG T, Long L, Chen Y, Li Y, et al
    Severe cervical inflammation and high-grade squamous intraepithelial lesions: a cross-sectional study.
    Arch Gynecol Obstet. 2021;303:547-556.
    PubMed    
    Abstract available

  236. INKMAN MJ, Jayachandran K, Ellis TM, Ruiz F, et al
    HPV-EM: an accurate HPV detection and genotyping EM algorithm.
    Sci Rep. 2020;10:14340.
    PubMed    
    Abstract available

  237. FU Y, Wang X, Lu W
    A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
    J Low Genit Tract Dis. 2020;24:425.
    PubMed    


  238. LI J, Peng K, Li Y, Wang J, et al
    Exosome-Mimetic Supramolecular Vesicles with Reversible and Controllable Fusion and Fission*.
    Angew Chem Int Ed Engl. 2020;59:21510-21514.
    PubMed    
    Abstract available

  239. LIN M, Zhang Q, Song Y, Yu X, et al
    Differentiation of endometrial adenocarcinoma from adenocarcinoma of cervix using kinetic parameters derived from DCE-MRI.
    Eur J Radiol. 2020;130:109190.
    PubMed    
    Abstract available

  240. HALLAM N, Parker J
    HPV Catch-up Vaccination Reduces the Prevalence of HPV 16 and 18 Infections and Cervical Disease: A Retrospective Study.
    J Low Genit Tract Dis. 2020;24:421.
    PubMed    


  241. MANDAL R, Ghosh I, Banerjee D, Mittal S, et al
    Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
    Int J Gynecol Pathol. 2020;39:384-390.
    PubMed    
    Abstract available

  242. YORITA K, Hirano K, Kai Y, Tanaka Y, et al
    White Adipocytes of the Uterine Cervix Tend to Appear in Women of Older Age, Postmenopause Status, and Higher Body Mass Index.
    Int J Gynecol Pathol. 2020;39:379-383.
    PubMed    
    Abstract available


  243. Update on the ISGyP Endocervical Adenocarcinoma Project.
    Int J Gynecol Pathol. 2020;39:1.
    PubMed    


  244. AOKI T, Fukuhara S
    Associations of types of primary care facilities with adult vaccination and cancer screening in Japan.
    Int J Qual Health Care. 2020;32:373-378.
    PubMed    
    Abstract available

  245. SCARINCI IC, Hansen B, Kim YI
    HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention.
    Vaccine. 2020 Apr 27. pii: S0264-410X(20)30441.
    PubMed    
    Abstract available

  246. SCHIFFMAN M, Wentzensen N, Perkins RB, Guido RS, et al
    An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
    J Low Genit Tract Dis. 2020;24:87-89.
    PubMed    


  247. HOOD RB, Turner AN, Huber-Krum S, Lancaster KE, et al
    For Human Papillomavirus Self-Sampling, Stated Willingness Does Not Correspond With Subsequent Uptake by Rural Malawian Women.
    Sex Transm Dis. 2020;47:275-279.
    PubMed    
    Abstract available

  248. LAN L, Liang Z, Zhao Y, Mo Y, et al
    LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  249. DURMUS Y, Karalok A, Basaran D, Kamani MO, et al
    Can we predict surgical margin positivity while performing cervical excisional procedures?
    J Obstet Gynaecol. 2020;40:666-672.
    PubMed    
    Abstract available

  250. PECOURT M, Gondry J, Foulon A, Lanta-Delmas S, et al
    Value of large loop excision of the transformation zone (LLETZ) without histological proof of high-grade cervical intraepithelial lesion: Results of a two-year continuous retrospective study.
    J Gynecol Obstet Hum Reprod. 2020;49:101621.
    PubMed    
    Abstract available

  251. LIU Y, Di N, Tao X
    Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China.
    Hum Vaccin Immunother. 2020;16:116-123.
    PubMed    
    Abstract available

  252. WANG Y, Yao Y, Dou Y, Tang S, et al
    Chopstick technique used in laparoendoscopic single site radical hysterectomy for early stage cervical cancer.
    Sci Rep. 2021;11:6882.
    PubMed    
    Abstract available

  253. EJEGOD DM, Pedersen H, Quint W, Xu L, et al
    Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
    J Virol Methods. 2021 Mar 22:114118. doi: 10.1016/j.jviromet.2021.114118.
    PubMed    
    Abstract available

  254. YUAN T, Sun J, Tian J, Hu J, et al
    Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells.
    Toxicology. 2021 Mar 22:152762. doi: 10.1016/j.tox.2021.152762.
    PubMed    
    Abstract available

  255. ZHANG L, Wu ZA
    MicroRNA-378a-3p Downregulation as a Novel Biomarker with Poor Clinical Outcomes in Cervical Cancer.
    Biomed Environ Sci. 2021;34:213-221.
    PubMed    
    Abstract available

  256. CHEN Q, Qiu B, Zeng X, Hu L, et al
    Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
    Cancer Cell Int. 2021;21:182.
    PubMed    
    Abstract available

  257. POLJAK M, Cuschieri K, Waheed DE, Baay M, et al
    Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
    Acta Dermatovenerol Alp Pannonica Adriat. 2021;30:21-26.
    PubMed    
    Abstract available

  258. KILIC C, Kimyon Comert G, Cakir C, Yuksel D, et al
    Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis.
    J Obstet Gynaecol Res. 2021 Mar 25. doi: 10.1111/jog.14762.
    PubMed    
    Abstract available

  259. BORGER TN, Puleo GE, Rivera Rivera JN, Montgomery D, et al
    A descriptive study of cervical cancer survivors' persistent smoking behavior and perceived barriers to quitting.
    Psychol Addict Behav. 2021 Mar 25. pii: 2021-28515-001. doi: 10.1037/adb0000692.
    PubMed    
    Abstract available

  260. WANG Q, Zheng W
    Upregulation of CDC7 Associated with Cervical Cancer Incidence and Development.
    Biomed Res Int. 2021;2021:6663367.
    PubMed    
    Abstract available

  261. SALCEDO MP, Varon ML, Phoolcharoen N, Osman N, et al
    Building local capacity for cervical cancer prevention in low resource settings: Changing strategy during the COVID-19 pandemic.
    J Glob Health. 2021;11:03044.
    PubMed    


  262. LI W, Ping Z, Xuemei G, Minglian L, et al
    Retracted: Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase (MAP
    Med Sci Monit. 2021;27:e932350.
    PubMed    
    Abstract available

  263. JIANG L, Shi S, Li F, Shi Q, et al
    miR519d3p/HIF2alpha axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  264. SHARMA A, Biswas B, Sati B
    Attributes of screening and vaccination for cervical cancer: insights of an online survey among female school teachers of Kota, Rajasthan, India.
    Health Promot Perspect. 2021;11:45-53.
    PubMed    
    Abstract available

  265. LIU X, Zhang Y, Zheng P, Cui N, et al
    Msi1 inhibits cervical cancer cell apoptosis by downregulating BAK through AKT signaling.
    J Cancer. 2021;12:2422-2429.
    PubMed    
    Abstract available

  266. HSIAO YH, Yang SF, Chen YH, Chen TH, et al
    Updated applications of Ultrasound in Uterine Cervical Cancer.
    J Cancer. 2021;12:2181-2189.
    PubMed    
    Abstract available

  267. KIRUBARAJAN A, Leung S, Li X, Yau M, et al
    Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review.
    BMC Womens Health. 2021;21:122.
    PubMed    
    Abstract available

  268. ZHU L, Huang Y, Lam D, Gach HM, et al
    Targetability of cervical cancer by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated hyperthermia (HT) for patients receiving radiation therapy.
    Int J Hyperthermia. 2021;38:498-510.
    PubMed    
    Abstract available

  269. BA DM, Ssentongo P, Musa J, Agbese E, et al
    Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
    Cancer Epidemiol. 2021;72:101930.
    PubMed    
    Abstract available

  270. ROSENBERG K
    Transmission of Cervical Cancer from Mother to Child.
    Am J Nurs. 2021;121:48.
    PubMed    
    Abstract available

  271. JABLONSKA E, Li Q, Reszka E, Wieczorek E, et al
    Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer.
    Cancer Control. 2021;28:10732748211001808.
    PubMed    
    Abstract available

  272. PIYATHILAKE CJ, Kumar R, Crowley MR, Badiga S, et al
    Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
    J Obstet Gynaecol Res. 2021 Mar 23. doi: 10.1111/jog.14754.
    PubMed    
    Abstract available

  273. KRISHNAMOORTHY Y, Ganesh K, Sakthivel M
    Prevalence and determinants of breast and cervical cancer screening among women aged between 30 and 49 years in India: Secondary data analysis of National Family Health Survey - 4.
    Indian J Cancer. 2021 Jan 27. pii: 308044. doi: 10.4103.
    PubMed    
    Abstract available

  274. KASIUS JC, van der Velden J, Denswil NP, Tromp JM, et al
    Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment.
    Best Pract Res Clin Obstet Gynaecol. 2021 Feb 20. pii: S1521-6934(21)00019.
    PubMed    
    Abstract available

  275. WANG M, Gu H, Hu J, Liang J, et al
    Evaluation of a highly refined prediction model in knowledge-based volumetric modulated arc therapy planning for cervical cancer.
    Radiat Oncol. 2021;16:58.
    PubMed    
    Abstract available

  276. M M, V D, J H, D S, et al
    Serum concentrations of S100-A11 and AIF-1 are elevated in cervical cancer patients with lymph node involvement.
    Ceska Gynekol. 2021;86:17-21.
    PubMed    
    Abstract available

  277. M M, V D, J H, D S, et al
    Elevated serum concentrations of S100-A11 and AIF-1 in cervical dysplasia patients.
    Ceska Gynekol. 2021;86:11-15.
    PubMed    
    Abstract available

  278. HOU YX, Min CL, Ma LJ
    miR-520 predicates poor prognosis and inhibits the progression of cervical cancer.
    J Biol Regul Homeost Agents. 2021;35.
    PubMed    


  279. YONEOKA Y, Kato MK, Tanase Y, Uno M, et al
    The baseline recurrence risk of patients with intermediate-risk cervical cancer.
    Obstet Gynecol Sci. 2021;64:226-233.
    PubMed    
    Abstract available

  280. JACH R, Mazurec M, Trzeszcz M, Zimmer M, et al
    Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Ginekol Pol. 2021;92:165-173.
    PubMed    
    Abstract available

  281. BALLARI N, Rai B, Bahl A, Mittal BR, et al
    Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis.
    Tech Innov Patient Support Radiat Oncol. 2021;17:48-56.
    PubMed    
    Abstract available

  282. TIAN P, Zhang C, Ma C, Ding L, et al
    Decreased chromobox homologue 7 expression is associated with epithelial-mesenchymal transition and poor prognosis in cervical cancer.
    Open Med (Wars). 2021;16:410-418.
    PubMed    
    Abstract available

  283. YAO S, Sun H
    Expression and Clinical Significance of CREPT and CDK4 in Cervical Cancer.
    Iran J Public Health. 2021;50:418-420.
    PubMed    


  284. BAYDOUN A, Xu KE, Heo JU, Yang H, et al
    Synthetic CT Generation of the Pelvis in Patients With Cervical Cancer: A Single Input Approach Using Generative Adversarial Network.
    IEEE Access. 2021;9:17208-17221.
    PubMed    
    Abstract available

  285. FAN Q, Huang T, Sun X, Yang X, et al
    miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor alpha and androgen receptor in cervical cancer.
    Exp Ther Med. 2021;21:414.
    PubMed    
    Abstract available

  286. RASI BONAB F, Baghbanzadeh A, Ghaseminia M, Bolandi N, et al
    Molecular pathways in the development of HPV-induced cervical cancer.
    EXCLI J. 2021;20:320-337.
    PubMed    
    Abstract available

  287. KATANYOO K, Thavorncharoensap M, Chaikledkaew U, Riewpaiboon A, et al
    A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer.
    Expert Rev Pharmacoecon Outcomes Res. 2021.
    PubMed    
    Abstract available

  288. SONG J, Lu Y, Wang X, Peng W, et al
    A comparative study of four diffusion-weighted imaging models in the diagnosis of cervical cancer.
    Acta Radiol. 2021 Mar 20:2841851211002017. doi: 10.1177/02841851211002017.
    PubMed    
    Abstract available

  289. PHUA LC, Choi HCW, Wu J, Jit M, et al
    Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00321.
    PubMed    
    Abstract available

  290. CAI J, He X, Wang H, Dong W, et al
    Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
    Radiat Oncol. 2021;16:54.
    PubMed    
    Abstract available

  291. DADAK A, Ouyaba AT
    Developing the Attitude Scale for Protection From Cervical Cancer.
    J Nurs Meas. 2021 Mar 19. pii: JNM-D-19-00081. doi: 10.1891/JNM-D-19-00081.
    PubMed    
    Abstract available

  292. SMALL W JR, Kim YS, Joyce C, Surucu M, et al
    Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management.
    Brachytherapy. 2021 Mar 17. pii: S1538-4721(21)00038.
    PubMed    
    Abstract available

  293. SERBAN M, de Leeuw AAC, Tanderup K, Jurgenliemk-Schulz IM, et al
    Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
    Brachytherapy. 2021 Mar 17. pii: S1538-4721(21)00041.
    PubMed    
    Abstract available

  294. PULKKINEN J, Huhtala H, Kholova I
    The role of Pap smear in the diagnostics of endocervical adenocarcinoma.
    APMIS. 2021;129:195-203.
    PubMed    
    Abstract available

  295. KODAMA K, Yahata H, Okugawa K, Tomonobe H, et al
    Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.
    Int J Clin Oncol. 2021;26:770-776.
    PubMed    
    Abstract available

  296. NNAJI CA, Kuodi P, Walter FM, Moodley J, et al
    Effectiveness of interventions for improving timely diagnosis of breast and cervical cancers in low and middle-income countries: a systematic review protocol.
    BMJ Open. 2020;10:e042788.
    PubMed    
    Abstract available

  297. FISHER H, Audrey S, Chantler T, Finn A, et al
    Co-production of an educational package for the universal human papillomavirus (HPV) vaccination programme tailored for schools with low uptake: a participatory study protocol.
    BMJ Open. 2020;10:e039029.
    PubMed    
    Abstract available

  298. XIE Z, Wang F, Lin L, Duan S, et al
    An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells.
    Cancer Lett. 2020 Sep 12. pii: S0304-3835(20)30467.
    PubMed    
    Abstract available

  299. GONCHARENKO AA, Tarasyuk IA, Marfin YS, Grzhegorzhevskii KV, et al
    DDAO Controlled Synthesis of Organo-Modified Silica Nanoparticles with Encapsulated Fluorescent Boron Dipyrrins and Study of Their Uptake by Cancerous Cells.
    Molecules. 2020;25.
    PubMed    
    Abstract available

  300. LIN YC, Chen YC, Chen RY, Huang YX, et al
    Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  301. KIM N, Chang JS, Kim YB, Kim JS, et al
    Atlas-based auto-segmentation for postoperative radiotherapy planning in endometrial and cervical cancers.
    Radiat Oncol. 2020;15:106.
    PubMed    
    Abstract available

  302. NGUYEN MH, Nguyen DT, Nguyen PTM
    Apoptosis induction by alpha-mangostin-loaded nanoparticles in human cervical carcinoma cells.
    Z Naturforsch C J Biosci. 2020;75.
    PubMed    
    Abstract available

  303. CHEN R, Wong E, Wu L, Zhu Y, et al
    Toward universal human papillomavirus vaccination for adolescent girls in Hong Kong: a policy analysis.
    J Public Health Policy. 2020;41:170-184.
    PubMed    
    Abstract available

  304. KARAKUS SELCUK A, Yanikkerem E
    The effect of web-based education on Pap smear behaviours of teachers.
    Eur J Cancer Care (Engl). 2020;29:e13202.
    PubMed    
    Abstract available

  305. DAWIDOWICZ S, Le Breton J, Moscova L, Renard V, et al
    Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmesdagger.
    Fam Pract. 2020;37:15-24.
    PubMed    
    Abstract available

  306. MENG Q, Zhang R, Ding W, Mao B, et al
    Long noncoding RNA ZFAS1 promotes cell proliferation and tumor growth by upregulating LIN28 in cervical carcinoma.
    Minerva Med. 2020;111:511-514.
    PubMed    


  307. HAMMER A, Gravitt P
    Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening.
    Acta Obstet Gynecol Scand. 2021;100:371-372.
    PubMed    


  308. KYRGIOU M, Arbyn M, Bergeron C, Bosch FX, et al
    Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
    Br J Cancer. 2020;123:510-517.
    PubMed    
    Abstract available

  309. HALLE MK, Sodal M, Forsse D, Engerud H, et al
    A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
    Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01305.
    PubMed    
    Abstract available

  310. ARBYN M, Rezhake R, Yuill S, Canfell K, et al
    Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence.
    Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0787.
    PubMed    
    Abstract available

  311. CHEN J, Chen C, Zhan Y, Zhou L, et al
    Heterogeneity of interferon-mediated responses and tumor immunogenicity in cervical cancer patients receiving concurrent chemoradiotherapy.
    Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-20-4521.
    PubMed    
    Abstract available

  312. LIU W, Gong J, Xu H, Zhang D, et al
    Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Diagn Cytopathol. 2020;48:635-644.
    PubMed    
    Abstract available

  313. MATSUO K, Shimada M, Matsuzaki S, Enomoto T, et al
    Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic.
    Eur J Cancer. 2021;148:117-120.
    PubMed    


  314. SKORSTENGAARD M, Frederiksen ME, Baillet MV, Beau AB, et al
    Cervical cancer survivors and health care use: A Danish population-based register study.
    Gynecol Oncol. 2021 Feb 19. pii: S0090-8258(21)00139.
    PubMed    
    Abstract available

  315. CHANG CL, Ho SC, Su YF, Juan YC, et al
    DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
    PubMed    
    Abstract available

  316. ALHOLM Z, Monk BJ, Ting J, Pulgar S, et al
    Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
    Gynecol Oncol. 2021 Mar 16. pii: S0090-8258(21)00194.
    PubMed    
    Abstract available

  317. HALL MT, Smith MA, Simms KT, Barnabas R, et al
    Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33533.
    PubMed    
    Abstract available

  318. CHINULA L, Topazian HM, Mapanje C, Varela A, et al
    Uptake and safety of community-based 'screen-and-treat' with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Int J Cancer. 2021 Mar 9. doi: 10.1002/ijc.33549.
    PubMed    
    Abstract available

  319. LOOPIK DL, Ebisch RM, IntHout J, Melchers WJ, et al
    The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
    Int J Cancer. 2020;147:897-900.
    PubMed    
    Abstract available

  320. WALPOLE E, Dunn N, Youl P, Harden H, et al
    Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Int J Cancer. 2020;147:856-865.
    PubMed    
    Abstract available

  321. LOUVANTO K, Eriksson T, Gray P, Apter D, et al
    Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.
    Int J Cancer. 2020;147:440-447.
    PubMed    
    Abstract available

  322. SAND FL, Kjaer SK, Frederiksen K, Dehlendorff C, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
    Int J Cancer. 2019 Oct 24. doi: 10.1002/ijc.32752.
    PubMed    
    Abstract available

  323. CASTLE PE, Burk RD, Massad LS, Eltoum IE, et al
    Epidemiological Evidence that Common HPV Types May Be Common Because of Their Ability to Evade Immune Surveillance: Results from the Women's Interagency HIV Study.
    Int J Cancer. 2019 Oct 2. doi: 10.1002/ijc.32693.
    PubMed    
    Abstract available

  324. PONTI A, Basu P, Ritchie D, Anttila A, et al
    Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
    Int J Cancer. 2020;147:9-13.
    PubMed    
    Abstract available

  325. KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
    Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
    PubMed    
    Abstract available

  326. CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
    Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
    Int J Gynaecol Obstet. 2021;152:118-124.
    PubMed    
    Abstract available

  327. LIU P, Dai E, Li W, He F, et al
    Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2021;152:125-132.
    PubMed    
    Abstract available

  328. BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
    Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
    Int J Gynaecol Obstet. 2021;152:72-77.
    PubMed    
    Abstract available

  329. LI Y, Wang H, Zhang Y, Jing X, et al
    Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
    Int J Gynaecol Obstet. 2021;152:96-102.
    PubMed    
    Abstract available

  330. YANG Y, Hu T, Ming X, Yang E, et al
    REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Int J Gynaecol Obstet. 2021;152:82-87.
    PubMed    
    Abstract available

  331. CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
    Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
    PubMed    
    Abstract available

  332. MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
    The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
    Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
    PubMed    
    Abstract available

  333. FURUSAWA A, Takekuma M, Mori K, Usami T, et al
    A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
    Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
    PubMed    
    Abstract available

  334. LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
    Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
    Int J Gynecol Cancer. 2021;31:468-474.
    PubMed    
    Abstract available

  335. MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
    Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
    Int J Gynecol Cancer. 2021;31:457-461.
    PubMed    
    Abstract available

  336. FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
    Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
    Int J Gynecol Cancer. 2021;31:452-456.
    PubMed    
    Abstract available

  337. NICA A, Marchocki Z, Gien LT, Kupets R, et al
    Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
    Int J Gynecol Cancer. 2021;31:447-451.
    PubMed    
    Abstract available

  338. NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
    Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Int J Gynecol Cancer. 2021;31:379-386.
    PubMed    
    Abstract available

  339. BUONOMO B, Multinu F, Casarin J, Betella I, et al
    Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
    Int J Gynecol Cancer. 2021;31:360-370.
    PubMed    
    Abstract available

  340. CIBULA D
    Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
    Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
    PubMed    


  341. SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
    Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
    Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
    PubMed    


  342. LI R, Liu Y, Yin R, Yin L, et al
    The Dynamic alternation of Local and Systemic Tumor Immune Microenvironment during Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00243.
    PubMed    
    Abstract available

  343. YOU X, Wang Y, Meng J, Han S, et al
    Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
    Oncol Rep. 2021;45:1.
    PubMed    
    Abstract available

  344. SI J, Zhang J, Gan L, Guo M, et al
    The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
    Oncol Rep. 2020;44:303-312.
    PubMed    
    Abstract available

  345. WANG J, Xiang F, Liu X, Ma X, et al
    HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
    Oncol Rep. 2021;45.
    PubMed    
    Abstract available

  346. YANG X, Du H, Bian W, Li Q, et al
    FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
    Oncol Rep. 2021;45.
    PubMed    
    Abstract available

  347. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Brachytherapy for locally advanced cervical cancer: a survey of UK provision of care and support.
    Radiother Oncol. 2021 Mar 16. pii: S0167-8140(21)06133.
    PubMed    
    Abstract available

  348. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
    Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
    BMC Cancer. 2020;20:577.
    PubMed    
    Abstract available

  349. ARARSA T, Tadele N, Ayalew Y, Gela D, et al
    Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
    BMC Cancer. 2021;21:224.
    PubMed    
    Abstract available

  350. YANG E, Huang S, Ran X, Huang Y, et al
    The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    BMC Cancer. 2021;21:203.
    PubMed    
    Abstract available

  351. JU Z, Guo W, Gu S, Zhou J, et al
    CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
    BMC Cancer. 2021;21:243.
    PubMed    
    Abstract available

  352. KELLY HA, Chikandiwa A, Sawadogo B, Gilham C, et al
    Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    PLoS Med. 2021;18:e1003528.
    PubMed    
    Abstract available

  353. MANYAU PMC, Mabeka M, Mudzviti T, Kadzatsa W, et al
    Renal function impairment in cervical cancer patients treated with cisplatin-based chemoradiation: A review of medical records in a Zimbabwean outpatient department.
    PLoS One. 2021;16:e0245383.
    PubMed    
    Abstract available

  354. DEVINE A, Vahanian A, Sawadogo B, Zan S, et al
    Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
    PLoS One. 2021;16:e0248832.
    PubMed    
    Abstract available

  355. TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
    Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    PLoS One. 2020;15:e0244644.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;